Advances in Neurorestoratology-Current status and future developments

Neurorestoratology constitutes a novel discipline aimed at the restoration of damaged neural structures and impaired neurological functions. This area of knowledge integrates and compiles all concepts and strategies dealing with the neurorestoration. Although currently, this discipline has already been well recognized by physicians and scientists throughout the world, this article aimed at broadening its knowledge to the academic circle and the public society. Here we shortly introduced why and how Neurorestoratology was born since the fact that the central nervous system (CNS) can be repaired and the subsequent scientific evidence of the neurorestorative mechanisms behind, such as neurostimulation or neuromodulation, neuroprotection, neuroplasticity, neurogenesis, neuroregeneration or axonal regeneration or sprouting, neuroreplacement, loop reconstruction, remyelination, immunoregulation, angiogenesis or revascularization, and others. The scope of this discipline is the improvement of therapeutic approaches for neurological diseases and the development of neurorestorative strategies through the comprehensive efforts of experts in the different areas and all articulated by the associations of Neurorestoratology and its journals. Strikingly, this article additionally explores the "state of art" of the Neurorestoratology field. This includes the development process of the discipline, the achievements and advances of novel neurorestorative treatments, the most efficient procedures exploring and evaluating outcome after the application of pioneer therapies, all the joining of a multidisciplinary expert associations and the specialized journals being more and more impact. We believe that in a near future, this discipline will evolve fast, leading to a general application of cell-based comprehensive neurorestorative treatments to fulfill functional recovery demands for patients with neurological deficits or dysfunctions.

Different Time-Frequency Distribution Patterns of Somatosensory Evoked Potentials in Dual- and Single-Level Spinal Cord Compression

Among patients with cervical myelopathy, the most common level of stenosis at spinal cord of all ages was reported to be between cervical levels C5-6. Previous studies found that time-frequency components (TFCs) of somatosensory evoked potentials (SEPs) possess location information of spinal cord injury (SCI) in single-level deficits in the spinal cord. However, the clinical reality is that there are multiple compressions at multiple spinal cord segments. This study proposed a new algorithm to differentiate distribution patterns of SEP TFCs between the dual-level compression and the corresponding single-level compression, which is potential in providing precise diagnosis of cervical myelopathy. In the present animal study, a group of rats with dual-level compressive (C5+6) injury to cervical spinal cord was investigated. SEPs were collected at 2 weeks after surgery, while SEP TFCs were calculated. The SEP TFCs under dual-level compression were compared to an existent dataset with one sham control group and three single level compression groups at C4, C5, C6. Behavioral evaluation showed very similar scale of injury severity between individual rats, while histology evaluation confirmed the precise location of injury. According to time-frequency distribution patterns, it showed that the middle-energy components of dual-level showed similar patterns as that of each single-level group. In addition, the low-energy components of the dual-level C5+6 group had the highest correlation with C5 (R = 0.3423, p < 0.01) and C6 (R = 0.4000, p < 0.01) groups, but much lower with C4 group (R = 0.1071, p = 0.012). These results indicated that SEP TFCs components possess information regarding the location of neurological lesion after spinal cord compression. It preliminarily demonstrated that SEP TFCs are likely a useful measure to provide location information of neurological lesions after compression SCI.

Clinical neurorestorative cell therapies: Developmental process, current state and future prospective

Clinical cell therapies (CTs) for neurological diseases and cellular damage have been explored for more than 2 decades. According to the United States Food and Drug Administration, there are 2 types of cell categories for therapy, namely stem cell-derived CT products and mature/functionally differentiated cell-derived CT products. However, regardless of the type of CT used, the majority of reports of clinical CTs from either small sample sizes based on single-center phase 1 or 2 unblinded trials or retrospective clinical studies showed effects on neurological improvement and the ability to either partially or temporarily thwart the deteriorating cellular processes of the neurodegenerative diseases. There have been only a few prospective, multicenter, randomized, double- blind placebo-control clinical trials of CTs so far in this developing novel area that have shown negative results, and more clinical trials are needed. This will expand our knowledge in exploring the type of cells that yield promising results and restore damaged neurological structure and functions of the central nervous system based on higher level evidence-based medical data. In this review, we briefly introduce the developmental process, current state, and future prospective for clinical neurorestorative CT.

2018 Yearbook of Neurorestoratology

The Neurorestoratology discipline is getting worldwide attention from the clinicians, basic scientists, students and policy makers alike. Accordingly, this year too, the discipline has made profound advances and great achievements for the benefit of the mankind. In this report, of the 2018 Neurorestoratology Yearbook, salient features of new developments are summarized. This Yearbook consists 3 key themes namely (i) the new findings on pathogenesis of neurological diseases or degeneration; (ii) the new mechanisms of neurorestorative aspects; and (iii) the achievements and progresses made in the clinical field of neurorestorative therapies. The new trend has emerged in clinical studies that are based on greater levels of evidence-based medical practices both in clinical therapies and clinical trials based on standard designs.